Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Strategies to promote public engagement around deprescribing.
Turner JP, Currie J, Trimble J, Tannenbaum C. Turner JP, et al. Among authors: trimble j. Ther Adv Drug Saf. 2018 Sep 12;9(11):653-665. doi: 10.1177/2042098618794165. eCollection 2018 Nov. Ther Adv Drug Saf. 2018. PMID: 30479740 Free PMC article. Review.
Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial.
Mangin D, Lamarche L, Agarwal G, Banh HL, Dore Brown N, Cassels A, Colwill K, Dolovich L, Farrell B, Garrison S, Gillett J, Griffith LE, Holbrook A, Jurcic-Vrataric J, McCormack J, O'Reilly D, Raina P, Richardson J, Risdon C, Savelli M, Sherifali D, Siu H, Tarride JÉ, Trimble J, Ali A, Freeman K, Langevin J, Parascandalo J, Templeton JA, Dragos S, Borhan S, Thabane L. Mangin D, et al. Among authors: trimble j. Trials. 2021 Oct 26;22(1):746. doi: 10.1186/s13063-021-05685-9. Trials. 2021. PMID: 34702336 Free PMC article.
Team approach to polypharmacy evaluation and reduction: feasibility randomized trial of a structured clinical pathway to reduce polypharmacy.
Mangin D, Lamarche L, Agarwal G, Ali A, Cassels A, Colwill K, Dolovich L, Brown ND, Farrell B, Freeman K, Frizzle K, Garrison SR, Gillett J, Holbrook A, Jurcic-Vrataric J, McCormack J, Parascandalo J, Richardson J, Risdon C, Sherifali D, Siu H, Borhan S, Templeton JA, Thabane L, Trimble J. Mangin D, et al. Among authors: trimble j. Pilot Feasibility Stud. 2023 May 18;9(1):84. doi: 10.1186/s40814-023-01315-0. Pilot Feasibility Stud. 2023. PMID: 37202822 Free PMC article.
Linking Patients' Goals and Priorities to Recommendations for Medication Changes in a Polypharmacy-Focused Structured Clinical Pathway.
Mangin D, Lamarche L, Freeman K, Ali A, Clark R, Shah N, Awan A, Langevin J, Parascandalo J, Dore Brown N, Jurcic-Vrataric J, Colwill K, Dragos S, Borhan S, Risdon C, Siu H, Farrell B, Trimble J. Mangin D, et al. Among authors: trimble j. J Patient Exp. 2023 May 17;10:23743735231174762. doi: 10.1177/23743735231174762. eCollection 2023. J Patient Exp. 2023. PMID: 37213440 Free PMC article.
Theoretical Underpinnings of a Model to Reduce Polypharmacy and Its Negative Health Effects: Introducing the Team Approach to Polypharmacy Evaluation and Reduction (TAPER).
Mangin D, Lamarche L, Templeton JA, Salerno J, Siu H, Trimble J, Ali A, Varughese J, Page A, Etherton-Beer C. Mangin D, et al. Among authors: trimble j. Drugs Aging. 2023 Sep;40(9):857-868. doi: 10.1007/s40266-023-01055-z. Epub 2023 Aug 21. Drugs Aging. 2023. PMID: 37603255 Free PMC article.
143 results